Peter J. O’Dwyer
0000-0002-9302-4073
Publication & Citation Trends
Most Cited Works
Publications
766 total
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
Cited by 4
Semantic Scholar
Novel use of alternate (Alt) response (Rp) criteria (Cr) for early prediction of outcomes in pancreatic (P) neuroendocrine tumors (NETs): Utilizing banked imaging data from the ECOG-ACRIN E2211 study.
Cited by 0
Semantic Scholar
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer. OA
Cited by 16
Semantic Scholar
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B OA
Cited by 10
Semantic Scholar
Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials OA
Cited by 7
Semantic Scholar
Phase II study of crizotinib in patients with MET amplification and MET exon 14 deletion: Results from NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocols C1 and C2.
Cited by 2
Semantic Scholar
Optimal perioperative therapy for incidental gallbladder cancer (OPT-IN): A randomized phase II/III trial—ECOG-ACRIN EA2197.
Cited by 7
Semantic Scholar
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH) OA
Cited by 41
Semantic Scholar
The NCI-MATCH trial: lessons for precision oncology OA
Cited by 125
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(206)
Cancer Genomics and Diagnostics
(135)
Pancreatic and Hepatic Oncology Research
(112)
Lung Cancer Treatments and Mutations
(109)
Cancer Treatment and Pharmacology
(85)
Frequent Co-Authors
Affiliations
AstraZeneca (United Kingdom)
American College of Radiology
Northwestern University
Roche (Switzerland)
Universitat Autònoma de Barcelona